Sep 02, 2021 / Presentations

Mandated report: Impact of Bipartisan Budget Act 2018 changes to the home health prospective payment system

Research Areas:

Post-Acute Care

Sep 02, 2021 / Presentations

Mandated report: Designing a value incentive program for post-acute care

Research Areas:

Delivery System Reforms, Post-Acute Care

Sep 02, 2021 / Presentations

Potential reforms to Part D’s low-income premium subsidy

Research Areas:

Drugs, Devices, and Tests, Private Plans

Sep 02, 2021 / Presentations

Effects of the coronavirus public health emergency and considerations for MedPAC’s 2022 assessment of Medicare payment adequacy

Research Areas:

Ambulatory Care Settings, Hospitals, Physicians And Other Health Professionals, Post-Acute Care

Sep 02, 2021 / Presentations

Context for Medicare Payment Policy

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality

Aug 30, 2021 / Comment Letters

MedPAC comment on CMS’s proposed rule on the ESRD PPS update for CY 2022

Research Areas:

Ambulatory Care Settings, Delivery System Reforms

Aug 24, 2021 / Comment Letters

MedPAC comment on CMS’s proposed rule on the home health prospective payment system for CY 2022

Research Areas:

Medicare Spending and Financing, Post-Acute Care

Aug 12, 2021

Home

Jun 30, 2021 / Contractor Reports

Evaluating the CMS Methodology for Setting Private Payer Based Rates for Clinical Lab Tests: Final Report

Research Areas:

Drugs, Devices, and Tests

Jun 23, 2021 / Comment Letters

MedPAC comment on CMS’s proposed rule on the hospital inpatient prospective payment system and the long-term care hospital prospective payment system for FY 2022

Research Areas:

Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Post-Acute Care, Regional Issues